The company has posted a net loss of $11.64m for the second quarter of 2011, compared to net income of $6.88m for the same period in 2010.
Horizon Pharma’s loss from operations were $8.75m, compared to $11.96m for the same period prior year.
For the six months ended 30 June 2011, the company reported total revenues of $3.13m, compared to $1.66m for the same period in 2010.
Horizon Pharma has reported net income of $19.31m for the six months ended 30 June 2011, compared to $1.02m for the same period in 2010.
For the six months ended 30 June 2011, the company’s loss from operations were $15.74m, compared to $19.58m for the same period prior year.